Prime Capital Investment Advisors »

Aldeyra Therapeutics shares owned by Prime Capital Investment Advisors

Quarter-by-quarter ownership of Aldeyra Therapeutics (ALDX) shares owned by Prime Capital Investment Advisors from 13F filings

Historical chart of Prime Capital Investment Advisors investment in Aldeyra Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aldeyra Therapeutics held by Prime Capital Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aldeyra Therapeutics by Prime Capital Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $35k 10k 3.51

More positions owned by Prime Capital Investment Advisors

Vanguard Index Fds Total Stk Mkt Etf (VTI)
Invesco Qqq Tr Unit Ser 1 Etf (QQQ)
Spdr S&p 500 Etf Tr Tr Unit Etf (SPY)
Ishares Tr Us Treas Bd Etf Etf (GOVT)
Apple Stock (AAPL)
Schwab Strategic Tr Us Lrg Cap Etf Etf (SCHX)
Vanguard Index Fds S&p 500 Etf Etf (VOO)
Ishares Tr Core Us Aggbd Et Etf (AGG)
Microsoft Corp Stock (MSFT)
Ishares Tr Core S&p Ttl Stk Etf (ITOT)
Schwab Strategic Tr Intl Eqty Etf Etf (SCHF)
Schwab Strategic Tr Us Mid-cap Etf Etf (SCHM)
Vanguard Index Fds Value Etf Etf (VTV)
Ishares Tr Sp Smcp600vl Etf Etf (IJS)
Vanguard Mun Bd Fds Tax Exempt Bd Etf (VTEB)

View all positions for Prime Capital Investment Advisors

Top funds holding Aldeyra Therapeutics

Perceptive Advisors
Knoll Capital Management
Vanguard Group
Kennedy Capital Management
Dimensional Fund Advisors
Damian Sousa
Millennium Management
Thomas Stevens, CFA"
Bank of America Corporation
Two Sigma Advisers
Wells Fargo & Company
Deutsche Bank Aktiengesellschaft
D. E. Shaw & Co
Palo Alto Investors
Two Sigma Investments

View all funds holding Aldeyra Therapeutics